Role of interferon-γ and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection

Neuropathology and Applied Neurobiology

Volumn 29, Issue 6, 2003, Pages 553-562

  Keogh, B ^a,b   Atkins, G J ^b   Mills, K H G ^b   Sheahan, B J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

B cell; Cytokine; Immunohistochemistry; Interferon ; Macrophage; Nitric oxide; Semliki Forest virus; T cell

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEMLIKI FOREST ALPHAVIRUS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE SEVERITY; ENZYME DEFICIENCY; FRONTAL CORTEX; IMMUNOASSAY; INFLAMMATORY INFILTRATE; KNOCKOUT GENE; KNOCKOUT MOUSE; MACROPHAGE; MACROPHAGE INFILTRATE; MOUSE; MOUSE STRAIN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; OLFACTORY BULB; PATHOGENESIS; PRIORITY JOURNAL; SEMLIKI FOREST ALPHAVIRUS; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE;

ALPHAVIRUS INFECTIONS; ANIMALS; ANTIGENS, VIRAL; BRAIN; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; MACROPHAGES; MICE; MICE, KNOCKOUT; NECROSIS; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, INTERFERON; SEMLIKI FOREST VIRUS; TH1 CELLS;

EID: 0346119029     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2003.00492.x     Document Type: Article

References (44)

1. Akaike T, Maeda H. Nitric oxide and virus infection. Immunol 2000; 101: 300-8
2. Amor S, Scallan M, Morris M, Dyson H, Fazakerley J. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J General Virol 1996; 77: 281-91
3. Atkins GJ, Sheahan BJ, Dimmock NJ. Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity. J General Virol 1985; 66: 395-408
4. Balluz IM, Gates G, Killen HM, Mobruk MJEMF, Sheahan BJ, Atkins GJ. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Neuropathol Appl Neurobiol 1993; 19: 233-9
5. Barrett PN, Sheahan BJ, Atkins GJ. Isolation and preliminary characterisation of Semliki Forest virus mutants with altered virulence. J General Virol 1980; 49: 141-7
6. Billiau A. Interferon-gamma: biology and role in pathogenesis. Adv Immunol 1996; 62: 61-130
7. Cannella B, Gao Y, Brosnan C, Raine CS. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res 1996; 45: 735-46
8. Ding M, Zhang M, Wong JL, Rogers NE, Ignarro LJ, Voskuhl RR. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J Immunol 1998; 160: 2560-4
9. Donnelly S, Sheahan BJ, Atkins GJ. Long term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathol Appl Neurobiol 1997; 23: 235-41
10. Fazakerley J, Webb H. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice. J General Virol 1987; 68: 377-85
11. Fenyk-Melody JE, Garrison A, Brunnert SR, Weidner JR, Shen F, Shelton BA, Mudgett JS. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 1998; 160: 2940-6
12. Harald H, Schmist W, Walter U. NO at work. Cell 1994; 78: 919-25
13. Hickey MJ, Sharkey K, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, Kubes P. InducibLe nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997; 11: 955-64
14. Holan V, Krulova M, Zajicova A, Pindjakova J. Nitric oxide as a regulatory and effector molecule in the immune system. Mol Immunol 2002; 38: 989-95
15. Juedes AE, Hjelmstrom P, Bergman CM, Neild AL, Ruddle NH. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 2000; 164: 419-26
16. Keogh B, Atkins GJ, Mills KH, Sheahan BJ. Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunity. J Neuroimmunol 2002; 125: 15-22
17. Knowles R, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-58
18. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytoxic or regulatory mediator? Immunol Today 1998; 19: 556-61
19. Levy DE, Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 2001; 12: 143-56
20. Liu J, Marino M, Wong G. Grail D, Dunn A, Bettadapura J, Slavin A, Old L, Bernard C. TNF is a potent antiinflammatory cytokine in autoimmune mediated demyelination. Nat Med 1998; 4: 78-83
21. Mackenzie A, Suckling A, Jagelman S, Wilson AM. Histopathological and enzyme histochemical changes in experimental Semliki Forest virus infection in mice and their relevance to scrapie. J Comp Path 1978; 88: 335-44
22. Mahon BP, Ryan M, Griffin F, Mills KH. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun 1996; 64: 5295-301
23. Marcinkiewicz J, Grabowska A, Chain B. Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 1995; 25: 947-51
24. Massey EJ, Sunstedt A, Day MJ, Corfield G, Anderton S, Wraith DC. Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T cell function within the context of experimental autoimmune encephalomyelitis. Vet Immunol Immunopathol 2002; 87: 357-72
25. Morris M, Dyson H, Baker D, Harbige L, Fazakerley J. Amor S. Characterisation of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J Neuroimmunol 1997; 74: 185-97
26. Nagelkerken L. Role of Th1 andTh2 cells in autoimmune demyelinating disease. Braz J Med Biol Res 1998; 31: 55-60
27. Noda S, Tanaka K, Sawamura S, Sasaki M, Matsumoto T, Mikami K, Aiba Y, Hasegawa H, Kawabe N, Koga Y. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus. J Immunol 2001; 166: 3533-41
28. Olszyna DP, Pajkrt D, Lauw FN, van Deventer SJ, van der Poll T. Interleukin 10 inhibits the release of CC chemokines during human endotoxemia. J Infect Dis 2001; 181: 613-20
29. Rao KL, Varalakshmi C, Ali AM, Khar A. Administration of anti-IL-12 antibody in vivo inhibits rejection of a rat histiocytoma and suppresses cytokine response in a tumour- bearing host. Immunol 1997; 92: 381-7
30. Reiss CS, Komatsu T. Does nitric oxide play a critical role in viral infections? J Virol 1998; 72: 4547-51
31. Rohn WM, Lee Y, Benveniste EN. Regulation of class II MHC expression. Crit Rev Immunol 1996; 16: 311-30
32. Rott O, Flescher B, Cash E. Interleukin-10 prevents experimental encephalomyelitis in rats. Eur J Immunol 1994; 24: 1434-40
33. Saxena SK, Mathur A, Srivastava RC. Induction of nitric oxide synthase during Japanese encephalitis virus infection: evidence of protective role. Arch Biochem Biophys 2001; 391: 1-7
34. Sheahan BJ, Gates MJ, Atkins GJ. Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus. Acta Neuropathol (Berl) 1983; 60: 257-65
35. Sheahan BJ, Ibrahim M, Atkins GJ. Demyelination of olfactory pathways in mice following intranasal infection with the avirulent A7 strain of Semliki Forest virus. Eur J Vet Path 1996; 2: 117-25
36. Sriram S, Topham D, Carroll L, Shenoy M, Adesina A, Craighead JE. In vivo administration of TNF-alpha prevents EMC-M virus induced viral encephalitis. Int Immunol 1991; 3: 641-5
37. Sriram S, Rodriguez M. Indictment of the microglia as the villain in multiple sclerosis. Neurol 1997; 48: 464-70
38. Subak-Sharpe I, Dyson H, Fazakerley J. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J Virol 1993; 67: 7629-33
39. TorreD, Pugliese A, Speranza F. Role of nitric oxide in HIV-1 infection: friend or foe? Lancet Infect Dis 2002; 2: 273-80
40. Ulchaker J, Panuto J, Rayman P, Novick A, Elson P, Tubbs R, Finke JH, Bukowski RM. Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12. J Immunother 1999; 22: 71-9
41. Whiteland JL, Nicholls S, Shimeld C, Easty DL, Williams NA, Hill TJ. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem 1995; 43: 313-20
42. Wildbaum G, Youssef S, Grabie N, Karin N. Neutralising antibodies to interferon-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J Immunol 1998; 161: 6368-74
43. Willenborg D, Fordham S, Staykova M, Ramshaw I, Cowden W. IFN-γ is critical to the control of marine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol 1999; 163: 5278-86
44. Zhao W, Tilton R, Corbett J, McDaniel M, Misko T, Williamson J, Cross A, Hickey W. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 1996; 64: 123-33